Co-encapsulation of human serum albumin and superparamagnetic iron oxide in PLGA nanoparticles: Part II. Effect of process variables on protein model drug encapsulation efficiency

References

• Allemann E, Leroux JC, Gurny R. Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics. Adv Drug Deliver Rev, 1998;34:171–89
   PubMed Web of Science ®Google Scholar
• Andujar CB, Ortega D, Pankhurst QA, Thanh NTK. Elucidating the morphological and structural evolution of iron oxide nanoparticles formed by sodium carbonate in aqueous medium. J Mater Chem, 2012;22:12498–506
   Google Scholar
• Biró E, Németh AS, Feczkó T, Tóth J, Sisak C, Gyenis J. Three-step experimental design to determine the effect of process parameters on the size of chitosan microspheres. Chem Eng Process, 2009;48:771–9
   Web of Science ®Google Scholar
• Budhian A, Siegel SJ, Winey KI. Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content. Int J Pharm, 2007;336:367–75
   PubMed Web of Science ®Google Scholar
• Burkersroda FV, Schedl L, Göpferich A. Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials, 2002;23:4221–31
   PubMed Web of Science ®Google Scholar
• Coimbra PA, De Sousa HC, Gil MH. Preparation and characterization of flurbiprofen-loaded poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres. J Microencapsul, 2008;25:170–8
   PubMed Web of Science ®Google Scholar
• Dey SK, Mandal B, Bhowmik M, Ghosh LK. Development and in vitro evaluation of Letrozole loaded biodegradable nanoparticles for breast cancer therapy. Braz J Pharm Sci, 2009;45:585–91
   Web of Science ®Google Scholar
• Dillen K, Vandervoort J, Mooter GV, Ludwig A. Evaluation of ciprofloxacin-loaded Eudragit® RS100 or RL100/PLGA nanoparticles. Int J Pharm, 2006;314:72–82
   PubMed Web of Science ®Google Scholar
• Feczkó T, Tóth J, Dósa G, Gyenis J. Influence of process conditions on the mean size of PLGA nanoparticles. Chem Eng Process, 2011a;50:846–53
   Web of Science ®Google Scholar
• Feczkó T, Tóth J, Dósa G, Gyenis J. Optimization of protein encapsulation in PLGA nanoparticles. Chem Eng Process, 2011b;50:757–65
   Web of Science ®Google Scholar
• Feczkó T, Tóth J, Gyenis J. Comparison of the preparation of PLGA–BSA nano- and microparticles by PVA, poloxamer and PVP. Colloid Surface A, 2008;319:188–95
   Web of Science ®Google Scholar
• Feng S, Huang G. Effects of emulsifiers on the controlled release of paclitaxel (TaxolÒ) from nanospheres of biodegradable polymers. J Control Release, 2001;71:53–69
   PubMed Web of Science ®Google Scholar
• Galindo-Rodriguez S, Allémann E, Fessi H, Doelker E. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res, 2004;21:1428–39
   PubMed Web of Science ®Google Scholar
• Gorner T, Gref R, Michenot D, Sommer F, Tran MN, Dellacherie E. Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix. J Control Release, 1999;57:259–68
   PubMed Web of Science ®Google Scholar
• Horák D, Semenyuk N, Lednický F. Effect of the reaction parameters on the particle size in the dispersion polymerization of 2-hydroxyethyl and glycidyl methacrylate in the presence of a ferrofluid. J Polym Sci A1, 2003;41:1848–63
   Web of Science ®Google Scholar
• Ibrahim A, Couvreur P, Roland M, Speiser P. New magnetic drug carrier. J Pharm Pharmacol, 1983;35:59–61
   PubMed Web of Science ®Google Scholar
• Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glicolide) (PLGA) devices. Biomaterials, 2000;21:2475–90
   PubMed Web of Science ®Google Scholar
• Jeon HJ, Jeong YL, Jang MK, Park YH, Nah JW. Effect of solvent on the preparation of surfactant-free poly(d,l-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics. Int J Pharm, 2000;207:99–108
   PubMed Web of Science ®Google Scholar
• Kusum VD, Bhosale UV. Formulation and optimization of polymeric nano drug delivery system of acyclovir using 32 full factorial design. Int J Pharm Tech Res, 2009;1:644–53
   Google Scholar
• Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: State of the art for process engineering approaches. Int J Pharm, 2008;363:26–39
   PubMed Web of Science ®Google Scholar
• Mainardes RM, Evangelista RC. PLGA nanoparticles containing praziquantel: Effect of formulation variables on size distribution. Int J Pharm, 2005;290:137–44
   PubMed Web of Science ®Google Scholar
• Maravajhala V, Dasari N, Sepuri A, Joginapalli S. Design and evaluation of niacin microspheres. Indian J Pharm Sci, 2009;71:663–9
   PubMed Web of Science ®Google Scholar
• Muller RH, Maassen S, Weyhers H, Mehnert W. Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J Drug Target, 1996;4:161–70
   PubMed Web of Science ®Google Scholar
• Nielsen SS. 2010. Food analysis part II, 4th edn. New York: Springer, p. 142
   Google Scholar
• Pamujula S, Graves RA, Kishore V, Mandal TK. Preparation and in vitro characterization of amifostine biodegradable microcapsules. Eur J Pharm Biopharm, 2004;57:213–18
   PubMed Web of Science ®Google Scholar
• Panyam J, Dali MM, Sahoo SK, Ma W, Chakravarthi SS, Amidon GL, Levy RJ, Labhasetwar V. Polymer degradation and in vitro release of a model protein from poly(d,l-lactide-co-glycolide) nano- and microparticles. J Control Release, 2003;92:173–87
   PubMed Web of Science ®Google Scholar
• Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliver Rev, 2003;55:329–47
   PubMed Web of Science ®Google Scholar
• Park TG. Degradation of poly(lactide-co-glicolide acid) microspheres: Effect of copolymer composition. Biomaterials, 1995;16:1123–30
   PubMed Web of Science ®Google Scholar
• Peppas LB. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int J Pharm, 1995;116:1–9
   Web of Science ®Google Scholar
• Sato H, Wang YM, Adachi I, Horikoshi I. Pharmacokinetics study of taxol-loaded poly(lactic-co-glycolic acid) microspheres containing isopropyl miristate after targeted delivery to the lung in mice. Biol Pharm Bull, 1996;19:1596–601
   PubMed Web of Science ®Google Scholar
• Scholes PD, Coombes AGA, Illum L, Daviz SS, Vert M, Davies MC. The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery. J Control Release, 1993;25:145–53
   Web of Science ®Google Scholar
• Song X, Zhao Y, Wu W, Bi Y, Cai Z, Chen Q, Li Y, Hou S. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: Systematic study of particle size and drug entrapment efficiency. Int J Pharm, 2008;350:320–9
   PubMed Web of Science ®Google Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release, 2001;70:1–20
   PubMed Web of Science ®Google Scholar
• Ubrich N, Bouillot P, Pellerin C, Hoffman M, Maincent P. Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study. J Control Release, 2004;97:291–300
   PubMed Web of Science ®Google Scholar
• Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM. Polymeric systems for controlled drug release. Chem Rev, 1999;11:3181–98
   Google Scholar
• Vert M, Schwach G, Engel R, Coudane J. Something new in the field of PLA/GA bioresorbable polymers? J Control Release, 1998;53:85–92
   PubMed Web of Science ®Google Scholar
• Wang YM, Sato H, Adachi I, Horikoshi I. Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent. Taxol Chem Pharm Bull, 1996;44:1935–40
   PubMed Web of Science ®Google Scholar
• Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J. Superparamagnetic iron oxide: Pharmacokinetics and toxicity. Am J Roentgenol, 1989;152:67–173
   Google Scholar
• Yang F, Bian C, Zhu L, Zhao G, Huang Z, Huang M. Effect of human serum albumin on drug metabolism: Structural evidence of esterase activity of human serum albumin. J Struct Biol, 2007;157:348–55
   PubMed Web of Science ®Google Scholar
• Zambaux MF, Bonneaux F, Gref R, Maincent P, Dellacherie E, Alonso MJ, Labrude P, Vigneron C. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J Control Release, 1998;50:31–40
   PubMed Web of Science ®Google Scholar
• Zhao H, Gagnon J, Häfeli UO. Process and formulation variables in the preparation of injectable and biodegradable magnetic microspheres. Biomagn Res Technol, 2007;5:2
   PubMedGoogle Scholar